Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CNS Pharmaceuticals, Inc. | Director | Restricted Stock Units | 147K | $44.1K | $0.30 | Apr 8, 2024 | Direct |
CNS Pharmaceuticals, Inc. | Director | Common stock | 33.5K | $10K | $0.30 | Feb 1, 2024 | Direct |
CNS Pharmaceuticals, Inc. | Director | Option to purchase common stock | 130K | Apr 8, 2024 | Direct | ||
CNS Pharmaceuticals, Inc. | Director | Series B Warrant to purchase common stock | 112K | Feb 1, 2024 | Direct | ||
CNS Pharmaceuticals, Inc. | Director | Series A Warrant to purchase common stock | 78.8K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CNSP | CNS Pharmaceuticals, Inc. | Apr 8, 2024 | 2 | $0 | 4 | Apr 10, 2024 | Director |
CNSP | CNS Pharmaceuticals, Inc. | Feb 1, 2024 | 3 | $10K | 4 | Feb 6, 2024 | Director |
CNSP | CNS Pharmaceuticals, Inc. | Sep 21, 2023 | 1 | $0 | 4/A | Oct 12, 2023 | Director |
CNSP | CNS Pharmaceuticals, Inc. | Mar 8, 2022 | 1 | $1.01K | 4 | Mar 9, 2022 | Director |
CNSP | CNS Pharmaceuticals, Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 16, 2021 | Director |